Navigation Links
EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York
Date:12/12/2012

PHOENIX, Dec. 12, 2012 /PRNewswire/ -- EastBridge Investment Group Corporation (OTCQB: EBIG), a provider of financial consulting services to companies in Asia ("EastBridge") today announced management teams of EastBridge and Cellular BioMedicine Group Corp have attended an investor conference held in New York city on Dec 04, 2012, organized by SeeThruEquity.

Keith Wong, CEO of EastBridge, commented, "Led by a team of seasoned management personnel and scientists, CBMG has developed cellular medicine technologies featuring autologous and allogeneic platforms. In collaboration with multiple Chinese AAA hospitals, CBMG maintains a pipeline of clinical trials including treatments for knee osteoarthritis, rheumatoid arthritis and lupus disease. Its cancer treatment therapies under development feature cytokine-induced killer (CIK) cells.  In addition, it is also working on a tumor cell targeted dendritic cells (TC-DC) clinical trial on liver cancer."

Steve Liu, CEO of CBMG, added, "We are very happy to see the response from the conference attendees to our presentation. Overall, we believe that our multiple platforms of stem cell based future products offer CBMG an engine for future growth."

About Cellular Biomedicine Group
Cellular Biomedicine Group, Ltd. is in the development of cell therapies for the treatment of certain cancer and degenerative diseases. Our developmental stem cell, progenitor cell, and immune cell projects are the result of collaborative research and development between scientists and doctors from the U.S. and China. Its flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com

About EastBridge
EastBridge Investment Group focuses on high-growth companies in Asia and in the United States, offering assistance with all aspects of IPOs, joint ventures and merchant banking services.  EastBridge targets industries in the fields of electronics, real estate, auto, metal, energy, environmental, bioscience and retail food distribution. To learn more about EastBridge Investment Group go to our web site: www.EbigCorp.com. To receive EBIG's email alert, send a blank email to info@EbigCorp.com.

Forward-Looking Statements
Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "expects," "plans," "intends," "estimates," "potential," or "continue," or similar terms or the negative of these terms. Although EastBridge and CBMG believe the expectations reflected in the forward-looking statements are reasonable, they cannot guarantee that the announced merger will in fact be consummated or that future results, levels of activity, performance or achievements will be obtained. Neither EastBridge nor CBMG has any obligation to update these forward-looking statements other than as required by law.


'/>"/>
SOURCE EastBridge Investment Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
2. Life Technologies to Present at Upcoming Investment Conferences in February
3. New investment aims to establish the UK as a global graphene research hub
4. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
5. City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters
6. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
7. Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives
8. Foundation Venture Capital Group Makes Eighth Start-Up Investment
9. Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York
10. David Lichtenstein: Biotechnology is Rich Area for Investment
11. Kansas Bioscience Authority Approves $700,000 in Investments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
Breaking Biology Technology:
(Date:6/22/2016)... WASHINGTON , June 22, 2016 On ... highly-anticipated call to industry to share solutions for the ... by U.S. Customs and Border Protection (CBP), explains that ... nationals are departing the United States ... criminals, and to defeat imposters. Logo - ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
Breaking Biology News(10 mins):